Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
MANILA,Philippines,Nov. 11,2024-- Start2 Group proudly launches the 2024 Philippines Startup Ecosystem Map at Philippine Startup Week,providing a visual snapshot of the nation\'s dynamic innovation la
BEIJING,Nov. 9,2024-- A report from People\'s Daily:Yunmeng county in central China\'s Hubei province is leveraging its rich historical and cultural resources to boost the development of cultural tour
Shanghai Electric signed new memoranda of cooperation and strategic agreements with Carrier Group and Svenska Kullagerfabriken AB (SKF) China Sales Co.,Ltd. at CIIE 2024
Announcing North Asia BIG BANG Beauty Tech Innovation Program 2024 Winnersand New Sustainability Track
SYDNEY,Nov. 4,2024-- Australian-founded brokerFP Marketsfurther cemented its position as a market leader,winning \'Most Trusted Broker - Global\',\'Broker of the Year - Asia\',and \'Fastest Growing B
SHANGHAI,Nov. 4,2024--As an authorized global distributor,Mouser Electronics,Inc. is focused on the rapid65 introduction of new products and technologies,giving customers an edge and helping speed ti
HONG KONG,Nov. 4,2024-- TheZ Label,a tech-centric venture building group in Hong Kong,has raised $11.4 million led by Beyond Ventures to build up a portfolio of products for global GenZ consumers. The
CHICAGO,Nov. 4,2024-- AtFABTECH 2024 in Orlando,October 15-17,Tailift showcased its latest advancements in intelligent manufacturing,attracting extensive industry attention. Known for its technical in
Part of HSBC\'s ASEAN Growth Fund,an accumulative commitment of over US$100 million to Funding Societies since its partnership established in 2022
SHANGHAI,Nov. 5,2024-- BioCity Biopharma (BioCity) announced late-breaking results of the 2-SUCCEED clinical trial of SC0062,a selective endothelin receptor type A (ETA) antagonist,for the treatment o
© OfficialAffairs
